US 10251896
Compositions for improving cell viability and methods of use thereof
granted A61KA61K31/192A61K31/575
Quick answer
US patent 10251896 (Compositions for improving cell viability and methods of use thereof) held by Amylyx Pharmaceuticals, Inc. expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amylyx Pharmaceuticals, Inc.
- Grant date
- Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/192, A61K31/575, A61P, A61P25/28